Exo
Edit

Exo

https://www.exo-imaging.com/
Last activity: 23.04.2024
Probably Closed
Categories: 3DArtificial IntelligenceDiagnosticsHardwareHealthTechManufacturingMedTechMobilityPlatformSemiconductor
Ultrasound Reinvented.

Exo is pioneering a high-performance ultrasound platform and AI for imaging and therapeutics.
Likes
13.19K
Followers
5.02K
Followers
8.38K
Mentions
34
Location: United States, California, Redwood City
Employees: 51-200
Total raised: $295M
Founded date: 2015

Investors 6

Funding Rounds 3

DateSeriesAmountInvestors
29.07.2021Series C$220M-
20.08.2020Series B$40M-
05.08.2019Series B$35M-

Mentions in press and media 34

DateTitleDescription
23.04.2024Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart FailureWhat You Should Know: Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performanc...
26.09.2023Exo® Introduces a New Age of Ultrasound with Exo Iris™ Exo (pronounced “echo”), a medical imaging software and device company, today unveiled a category-redefining handheld ultrasound device, Exo Iris™, to put high-performance medical imaging into the hands—and pockets—of every caregiver...
26.07.2022Exo® Acquires Medo AI to Make Medical Imaging as Easy as Snapping a Smartphone PhotoBy integrating Medo’s AI, Exo enables more caregivers in more settings to capture and interpret medical images – allowing faster and more accurate diagnoses and treatment
30.07.2021Medical device startup Exo raises US$ 220M to commercialize its ultrasound deviceUS-based Exo, a pioneering health information and devices company, raised US$ 220 million in a Series C investment round on 29 July 2021.
30.07.2021Exo Raises $220M in Series C FundingExo, a Redwood City CA-based health information and devices company, raised $220M in Series C funding. The round was led by RA Capital Management with participation from BlackRock, Sands Capital, Avidity Partners and Pura Vida Investments. ...
29.07.2021Exo nabs $220M as hand-held ultrasound race heats upThe field of hand-held ultrasound has captured investors’ attention, as companies race to build a future where healthcare providers can have instant access and a deeper understanding about their patients' conditions. Now—after raising just ...
29.07.2021Exo nabs $220M as hand-held ultrasound race heats up Clinical Quality Oversight ForumThe field of hand-held ultrasound has captured investors’ attention, as companies race to build a future where healthcare providers can have instant access and a deeper understanding about their patients' conditions. Pronounced “echo,” Exo ...
29.07.2021Exo Raises $220M to Commercialize Handheld, Point-of-Care Ultrasound DeviceWhat You Should Know: – Exo (pronounced “echo”), a pioneering health information and devices company, announced it has raised $220M in Series C investment round led by RA Capital Management and joined by BlackRock, Sands Capital, Avidity Pa...
29.07.2021Exo raises $220M to make ultrasounds cheaper, easier, and ubiquitousThe company has developed a handheld ultrasound device, along with a software platform This almost seems hard to believe but, according to the World Health Organization, somewhere between 75% and 80% of the world's population has no access ...
29.07.2021Exo secures $200M toward commercializing ultrasound deviceExo, pronounced “echo,” raised a fresh cash infusion of $220 million in Series C financing aimed at commercializing its handheld ultrasound device and point-of-care workflow platform, Exo Works. The round was led by RA Capital Management, w...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In